RegDesk Regulatory Roundup

FDA’s Guidance on Placebos North America

FDA’s Guidance on Placebos

The FDA finalized guidance regarding the use of placebos and blinding during randomized cancer trials. The guidance finalizes a draft made in 2018 and clarifies scenarios where placebo designs and blindings should be justified. WHAT IS A PLACEBO? A placebo is an inert...

Read More